Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 9,868 shares at $1.72 ($17K) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $17k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 4,439 | $8K | 45.0% |
| 2 | $1.72 | 4,629 | $8K | 46.9% |
| 3 | $1.73 | 400 | $690 | 4.1% |
| 4 | $1.73 | 400 | $692 | 4.1% |
| Total | $1.72 avg | 9,868 | $17K | 100% |
| Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |
| ATNM | SELL | 2016-07-07 | $38K | — | Filing → |